Samuel T. Wilkinson

6.1k total citations · 1 hit paper
89 papers, 3.3k citations indexed

About

Samuel T. Wilkinson is a scholar working on Pharmacology, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, Samuel T. Wilkinson has authored 89 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pharmacology, 29 papers in Psychiatry and Mental health and 23 papers in Biological Psychiatry. Recurrent topics in Samuel T. Wilkinson's work include Treatment of Major Depression (49 papers), Electroconvulsive Therapy Studies (26 papers) and Tryptophan and brain disorders (23 papers). Samuel T. Wilkinson is often cited by papers focused on Treatment of Major Depression (49 papers), Electroconvulsive Therapy Studies (26 papers) and Tryptophan and brain disorders (23 papers). Samuel T. Wilkinson collaborates with scholars based in United States, United Kingdom and Canada. Samuel T. Wilkinson's co-authors include Gerard Sanacora, Rajiv Radhakrishnan, Taeho Greg Rhee, Deepak Cyril D’Souza, Sanjay J. Mathew, Michael H. Bloch, James W. Murrough, Robert A. Rosenheck, Mark Olfson and Carlos A. Zarate and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Samuel T. Wilkinson

80 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

2017 476 citations Samuel T. Wilkinson, Elizabeth D. Ballard et al. American Journal of Psychiatry profile →

Peers

Samuel T. Wilkinson

PHARM

PMH

CMN

S. Danielle Canada

Richard C. Shelton United States

Yu Hayasaka Japan

Charles DeBattista United States

Ioline D. Henter United States

Nancy Diazgranados United States

Manish K. Jha United States

Kiyomi Shinohara Japan

Chiara Fabbri Italy

Tom Bschor Germany

S. Danielle Canada

Samuel T. Wilkinson

1.5k ×0.6

PHARM

1.1k ×1.0

1.2k ×1.3

PMH

504 ×0.8

317 ×0.5

CMN

Citations per year, relative to Samuel T. Wilkinson Samuel T. Wilkinson (= 1×) peers S. Danielle

Countries citing papers authored by Samuel T. Wilkinson

Since Specialization

Citations

This map shows the geographic impact of Samuel T. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel T. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel T. Wilkinson more than expected).

Fields of papers citing papers by Samuel T. Wilkinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel T. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel T. Wilkinson. The network helps show where Samuel T. Wilkinson may publish in the future.

Co-authorship network of co-authors of Samuel T. Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel T. Wilkinson. A scholar is included among the top collaborators of Samuel T. Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel T. Wilkinson. Samuel T. Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanacora, Gerard, Brian S. Barnett, Bo Hu, et al.. (2025). Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysis. Psychiatry Research. 347. 116411–116411.

Cranney, Stephen & Samuel T. Wilkinson. (2025). The relationship between marital status and risk for suicidal thoughts, plans, and attempts: Evidence for a growing association. Journal of Affective Disorders. 391. 119862–119862.

Bryan, Craig J., Patricia Simon, Samuel T. Wilkinson, et al.. (2025). A Digital Therapeutic Intervention for Inpatients With Elevated Suicide Risk. JAMA Network Open. 8(8). e2525809–e2525809.

Pittman, Brian, et al.. (2024). Blood pressure changes during ketamine infusion for the treatment of depression. General Hospital Psychiatry. 90. 62–67.

Nikayin, Sina, et al.. (2024). Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical Setting. The Journal of Clinical Psychiatry. 85(4). 5 indexed citations

Wilkinson, Samuel T., et al.. (2023). Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study. CNS Drugs. 37(8). 715–723. 16 indexed citations

Kitay, Brandon M., Matthew Macaluso, Philip R. Corlett, et al.. (2023). Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol. Psychiatry Research. 330. 115585–115585. 4 indexed citations

Wilkinson, Samuel T., et al.. (2023). The Role of Psychotherapy in the Management of Treatment-Resistant Depression. Psychiatric Clinics of North America. 46(2). 349–358. 5 indexed citations

Chen, Li, Rosanne Lane, Wayne C. Drevets, et al.. (2023). Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study. Neuropsychopharmacology. 48(8). 1225–1233. 69 indexed citations

10.

Wilkinson, Samuel T., Kyaw Sint, Brent P. Forester, & Taeho Greg Rhee. (2023). Effects of Electroconvulsive Therapy on Functional Outcomes Among Medicare Patients With Comorbid Depression and Dementia. The Journal of Clinical Psychiatry. 84(2). 2 indexed citations

11.

Chouairi, Fouad, Michael Fuery, Clancy W. Mullan, et al.. (2021). The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT Trial. Journal of Cardiac Failure. 27(12). 1359–1366. 2 indexed citations

12.

Turkoz, Ibrahim, Ella Daly, Jaskaran Singh, et al.. (2021). Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response. The Journal of Clinical Psychiatry. 82(4). 17 indexed citations

13.

Wilkinson, Samuel T., Taeho Greg Rhee, Jutta Joormann, et al.. (2021). Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial. Psychotherapy and Psychosomatics. 90(5). 318–327. 57 indexed citations

14.

Davoudian, Pasha A. & Samuel T. Wilkinson. (2020). Clinical overview of NMDA-R antagonists and clinical practice. Advances in pharmacology. 89. 103–129. 11 indexed citations

15.

Rhee, Taeho Greg, Mark Olfson, Kyaw Sint, & Samuel T. Wilkinson. (2020). Characterization of the Quality of Electroconvulsive Therapy Among Older Medicare Beneficiaries. The Journal of Clinical Psychiatry. 81(4). 11 indexed citations

16.

Katz, Eva G., Abigail I. Nash, Ella Daly, et al.. (2020). PMH51 WHAT ARE THE ATTRIBUTES THAT PSYCHIATRISTS CONSIDER IN THE DECISION TO DISCHARGE ADULTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE BEEN HOSPITALIZED WITH ACTIVE SUICIDAL IDEATION WITH INTENT?. Value in Health. 23. S210–S210. 1 indexed citations

17.

Wilkinson, Samuel T. & Gerard Sanacora. (2018). A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems. Drug Discovery Today. 24(2). 606–615. 127 indexed citations

18.

Wilkinson, Samuel T., Elizabeth D. Ballard, Michael H. Bloch, et al.. (2017). The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. American Journal of Psychiatry. 175(2). 150–158. 476 indexed citations breakdown →

19.

Wilkinson, Samuel T., Robert Ostroff, & Gerard Sanacora. (2016). Computer-Assisted Cognitive Behavior Therapy to Prevent Relapse Following Electroconvulsive Therapy. Journal of Ect. 33(1). 52–57. 14 indexed citations

20.

Wilkinson, Samuel T., Elina A. Stefanovics, & Robert A. Rosenheck. (2015). Marijuana Use Is Associated With Worse Outcomes in Symptom Severity and Violent Behavior in Patients With Posttraumatic Stress Disorder. The Journal of Clinical Psychiatry. 76(9). 1174–1180. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact